Industry Growth Insights published a new data on “Arthritis Monoclonal Antibodies Market”. The research report is titled “Arthritis Monoclonal Antibodies Market research by Types (Remicade, Humira, Enbrel, Rituxan, Orencia, Actemra, Simponi, Cimzia), By Applications (Rheumatoid Arthritis, Osteoarthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Fibromyalgia, Others), By Players/Companies AbbVie Inc, F. Hoffmann-La Roche Ltd, Novartis, Johnson & Johnson(Janssen), Pfizer Inc, Mylan, Genentech, GSK, AstraZeneca PLC”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Arthritis Monoclonal Antibodies Market Research Report
By Type
Remicade, Humira, Enbrel, Rituxan, Orencia, Actemra, Simponi, Cimzia
By Application
Rheumatoid Arthritis, Osteoarthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Fibromyalgia, Others
By Companies
AbbVie Inc, F. Hoffmann-La Roche Ltd, Novartis, Johnson & Johnson(Janssen), Pfizer Inc, Mylan, Genentech, GSK, AstraZeneca PLC
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
128
Number of Tables & Figures
90
Customization Available
Yes, the report can be customized as per your need.
Global Arthritis Monoclonal Antibodies Market Report Segments:
The global Arthritis Monoclonal Antibodies market is segmented on the basis of:
Types
Remicade, Humira, Enbrel, Rituxan, Orencia, Actemra, Simponi, Cimzia
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Rheumatoid Arthritis, Osteoarthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Fibromyalgia, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AbbVie Inc
- F. Hoffmann-La Roche Ltd
- Novartis
- Johnson & Johnson(Janssen)
- Pfizer Inc
- Mylan
- Genentech
- GSK
- AstraZeneca PLC
Highlights of The Arthritis Monoclonal Antibodies Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Remicade
- Humira
- Enbrel
- Rituxan
- Orencia
- Actemra
- Simponi
- Cimzia
- By Application:
- Rheumatoid Arthritis
- Osteoarthritis
- Psoriatic Arthritis
- Ankylosing Spondylitis
- Fibromyalgia
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Arthritis Monoclonal Antibodies Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Arthritis monoclonal antibodies (AMA) are a type of antibody that is produced by the body in response to an infection or other injury. They are specifically designed to attack and destroy specific cells in the body, such as those that cause arthritis.
Some of the key players operating in the arthritis monoclonal antibodies market are AbbVie Inc, F. Hoffmann-La Roche Ltd, Novartis, Johnson & Johnson(Janssen), Pfizer Inc, Mylan, Genentech, GSK, AstraZeneca PLC.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Arthritis Monoclonal Antibodies Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Arthritis Monoclonal Antibodies Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Arthritis Monoclonal Antibodies Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Arthritis Monoclonal Antibodies Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Arthritis Monoclonal Antibodies Market Size & Forecast, 2018-2028 4.5.1 Arthritis Monoclonal Antibodies Market Size and Y-o-Y Growth 4.5.2 Arthritis Monoclonal Antibodies Market Absolute $ Opportunity
Chapter 5 Global Arthritis Monoclonal Antibodies Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Arthritis Monoclonal Antibodies Market Size Forecast by Type
5.2.1 Remicade
5.2.2 Humira
5.2.3 Enbrel
5.2.4 Rituxan
5.2.5 Orencia
5.2.6 Actemra
5.2.7 Simponi
5.2.8 Cimzia
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Arthritis Monoclonal Antibodies Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Arthritis Monoclonal Antibodies Market Size Forecast by Applications
6.2.1 Rheumatoid Arthritis
6.2.2 Osteoarthritis
6.2.3 Psoriatic Arthritis
6.2.4 Ankylosing Spondylitis
6.2.5 Fibromyalgia
6.2.6 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Arthritis Monoclonal Antibodies Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Arthritis Monoclonal Antibodies Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Arthritis Monoclonal Antibodies Analysis and Forecast
9.1 Introduction
9.2 North America Arthritis Monoclonal Antibodies Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Arthritis Monoclonal Antibodies Market Size Forecast by Type
9.6.1 Remicade
9.6.2 Humira
9.6.3 Enbrel
9.6.4 Rituxan
9.6.5 Orencia
9.6.6 Actemra
9.6.7 Simponi
9.6.8 Cimzia
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Arthritis Monoclonal Antibodies Market Size Forecast by Applications
9.10.1 Rheumatoid Arthritis
9.10.2 Osteoarthritis
9.10.3 Psoriatic Arthritis
9.10.4 Ankylosing Spondylitis
9.10.5 Fibromyalgia
9.10.6 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Arthritis Monoclonal Antibodies Analysis and Forecast
10.1 Introduction
10.2 Europe Arthritis Monoclonal Antibodies Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Arthritis Monoclonal Antibodies Market Size Forecast by Type
10.6.1 Remicade
10.6.2 Humira
10.6.3 Enbrel
10.6.4 Rituxan
10.6.5 Orencia
10.6.6 Actemra
10.6.7 Simponi
10.6.8 Cimzia
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Arthritis Monoclonal Antibodies Market Size Forecast by Applications
10.10.1 Rheumatoid Arthritis
10.10.2 Osteoarthritis
10.10.3 Psoriatic Arthritis
10.10.4 Ankylosing Spondylitis
10.10.5 Fibromyalgia
10.10.6 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Arthritis Monoclonal Antibodies Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Arthritis Monoclonal Antibodies Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Arthritis Monoclonal Antibodies Market Size Forecast by Type
11.6.1 Remicade
11.6.2 Humira
11.6.3 Enbrel
11.6.4 Rituxan
11.6.5 Orencia
11.6.6 Actemra
11.6.7 Simponi
11.6.8 Cimzia
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Arthritis Monoclonal Antibodies Market Size Forecast by Applications
11.10.1 Rheumatoid Arthritis
11.10.2 Osteoarthritis
11.10.3 Psoriatic Arthritis
11.10.4 Ankylosing Spondylitis
11.10.5 Fibromyalgia
11.10.6 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Arthritis Monoclonal Antibodies Analysis and Forecast
12.1 Introduction
12.2 Latin America Arthritis Monoclonal Antibodies Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Arthritis Monoclonal Antibodies Market Size Forecast by Type
12.6.1 Remicade
12.6.2 Humira
12.6.3 Enbrel
12.6.4 Rituxan
12.6.5 Orencia
12.6.6 Actemra
12.6.7 Simponi
12.6.8 Cimzia
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Arthritis Monoclonal Antibodies Market Size Forecast by Applications
12.10.1 Rheumatoid Arthritis
12.10.2 Osteoarthritis
12.10.3 Psoriatic Arthritis
12.10.4 Ankylosing Spondylitis
12.10.5 Fibromyalgia
12.10.6 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Arthritis Monoclonal Antibodies Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Arthritis Monoclonal Antibodies Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Arthritis Monoclonal Antibodies Market Size Forecast by Type
13.6.1 Remicade
13.6.2 Humira
13.6.3 Enbrel
13.6.4 Rituxan
13.6.5 Orencia
13.6.6 Actemra
13.6.7 Simponi
13.6.8 Cimzia
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Arthritis Monoclonal Antibodies Market Size Forecast by Applications
13.10.1 Rheumatoid Arthritis
13.10.2 Osteoarthritis
13.10.3 Psoriatic Arthritis
13.10.4 Ankylosing Spondylitis
13.10.5 Fibromyalgia
13.10.6 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Arthritis Monoclonal Antibodies Market: Competitive Dashboard
14.2 Global Arthritis Monoclonal Antibodies Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AbbVie Inc
14.3.2 F. Hoffmann-La Roche Ltd
14.3.3 Novartis
14.3.4 Johnson & Johnson(Janssen)
14.3.5 Pfizer Inc
14.3.6 Mylan
14.3.7 Genentech
14.3.8 GSK
14.3.9 AstraZeneca PLC